Czechia vs Lebanon: The number of people with susceptibility test result for rifampicin
Czechia
89.51
in 2021
Lebanon
91.2
in 2021
Czechia rank
68th
Lebanon rank
66th
The number of people with susceptibility test result for rifampicin over time
- Czechia
- Lebanon
How they compare
Lebanon currently reports 91.2 against 89.51 in Czechia, a difference of 1.69.
Across all 5 years both countries report, Lebanon has been ahead every year.
Czechia ranks 68th and Lebanon ranks 66th of 146 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.46 | 92.21 | 5.75 | Lebanon |
| 2020s | 87.15 | 92.99 | 5.84 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Czechia or Lebanon?
- Lebanon, at 91.2 against 89.51 in Czechia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Czechia and Lebanon?
- 1.69, with Lebanon ahead.
- How many years of comparable data are there for Czechia and Lebanon?
- 5 years are reported by both, from 2017 to 2021.
- How do Czechia and Lebanon rank globally for the number of people with susceptibility test result for rifampicin?
- Czechia ranks 68th and Lebanon ranks 66th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.